Relay Therapeutics Inc. (RLAY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Relay Therapeutics Inc.

    NASDAQ: RLAY · Real-Time Price · USD
    4.12
    0.06 (1.48%)
    At close: Sep 11, 2025, 10:41 AM

    Relay Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10.01M 25.55M 1.38M 3.03M
    Cost of Revenue
    		 5.46M 5.27M 4.13M 3.92M
    Gross Profit
    		 -305.43M 25.55M -241.62M -166.36M
    Operating Income
    		 -372.47M -373M -299.27M -364.7M
    Interest Income
    		 34.75M 31.05M 8.79M 830K
    Pretax Income
    		 -337.71M -341.97M -290.51M -363.87M
    Net Income
    		 -337.71M -341.97M -290.51M -363.87M
    Selling & General & Admin
    		 76.59M 74.95M 65.98M 57.39M
    Research & Development
    		 319.09M 330.02M 246.35M 172.65M
    Other Expenses
    		 -328.65M -6.42M -254.68M -31.7M
    Operating Expenses
    		 67.03M 398.55M 57.65M 198.34M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 382.48M 398.55M 300.66M 367.73M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 142.87M 122.58M 112.23M 95.14M
    Shares Outstanding (Diluted)
    		 142.87M 122.58M 112.23M 95.14M
    EPS (Basic)
    		 -2.36 -2.79 -2.59 -3.82
    EPS (Diluted)
    		 -2.36 -2.79 -2.59 -3.82
    EBITDA
    		 -380.21M -374.15M -306.82M -222.18M
    EBIT
    		 -385.67M -379.42M -310.95M -227.01M
    Depreciation & Amortization
    		 5.46M 5.27M 4.13M 3.92M

    Add to Watchlist